slug: hepatic-lipidosis
nameEn: Hepatic Lipidosis
nameZh: 肝臟脂肪變性
bodySystem: gastrointestinal
description: 貓特有的嚴重肝臟疾病，大量三酸甘油酯蓄積於肝細胞導致肝功能衰竭。為貓最常見的肝臟疾病。

aliases:
  - { alias: Fatty Liver Disease, language: en }
  - { alias: Feline Hepatic Lipidosis, language: en }
  - { alias: FHL, language: en }
  - { alias: 貓脂肪肝, language: zh }

species:
  - speciesCommon: cat
    speciesScientific: Felis catus
    prevalence: common
    notes: 貓最常見肝臟疾病。好發中年肥胖貓。厭食 2-7 天即可誘發。60% 有潛在原發疾病 (繼發性)。

etiology:
  categories:
    - name: 原發性 (特發性)
      examples:
        - 肥胖貓長時間 (>2-3 天) 厭食
        - 突然飲食改變或壓力事件導致食慾廢絕
        - 脂質代謝異常 (VLDL 組裝/分泌缺陷)
    - name: 繼發性 (約 60%)
      examples:
        - 胰臟炎
        - IBD / 慢性腸病
        - 膽管炎/膽管肝炎
        - 糖尿病
        - 腎臟疾病
        - 腫瘤
        - 上呼吸道感染 (嗅覺喪失→厭食)
    - name: 病理機轉
      examples:
        - 厭食→周邊脂肪動員→肝臟過度攝取脂肪酸
        - 蛋白質/營養不足→VLDL 合成障礙→脂肪無法輸出
        - 肝細胞 >80% 空泡化→膽汁淤滯→肝功能衰竭

clinicalSigns:
  early:
    - 食慾下降/厭食 (2-7 天)
    - 嗜睡
    - 體重減輕 (肥胖貓急速消瘦)
  progressive:
    - 嘔吐
    - 黃疸 (皮膚、黏膜、鞏膜黃染)
    - 脫水
    - 肝腫大 (可觸診)
    - 肌肉萎縮
  late:
    - 肝性腦病 (行為改變、流涎、頭部壓牆)
    - 凝血異常 (維生素 K 吸收障礙)
    - 低鉀血症 (肌肉無力、頸部下垂)
    - 嚴重膽汁淤滯

diagnosis:
  primaryTests:
    - name: 肝指數 (ALT、AST、ALP、GGT)
      notes: "ALP 顯著升高 (>500 U/L 常見)。GGT 正常或僅輕度升高 (GGT/ALP 比低為肝脂肪變性特徵；GGT↑↑提示膽管炎)"
    - name: 膽紅素
      notes: "明顯升高 (總膽紅素 >5 mg/dL 常見)"
    - name: 細針抽吸 (FNA) 或肝臟切片
      notes: "FNA 細胞學：肝細胞內大量脂肪空泡。確診標準。超音波導引安全性高"
  imaging:
    - name: 腹部超音波
      notes: "肝臟瀰漫性高迴音 (較腎臟皮質亮)、肝腫大。評估膽道系統、胰臟、其他器官"
  additional:
    - CBC (非特異性變化)
    - 生化 (低白蛋白、低 BUN、高膽固醇、電解質異常)
    - 凝血功能 (PT/APTT 可能延長)
    - 膽汁酸 (升高)
    - 血氨 (肝性腦病時升高)
    - 電解質 (低鉀、低磷、低鎂)

treatment:
  principles:
    - 營養支持為治療核心 (放置食道管或鼻胃管)
    - 矯正脫水與電解質異常
    - 找出並治療潛在原發疾病
    - 強制灌食至少 4-6 週
  medications:
    - name: Vitamin K1
      dose: "0.5-1.5 mg/kg SC BID-TID × 3 劑"
      notes: 矯正凝血異常。放置食道管前須先給予
    - name: Mirtazapine
      dose: "1.88 mg/cat PO q48h 或 transdermal 2 mg/cat q48h"
      notes: 食慾促進劑，輔助恢復自主進食
    - name: Maropitant
      dose: "1 mg/kg SC/IV SID"
      notes: 止吐
    - name: SAMe (S-adenosylmethionine)
      dose: "90 mg/cat PO SID 空腹"
      notes: 肝臟保護、抗氧化
    - name: L-Carnitine
      dose: "250-500 mg/cat/day PO"
      notes: 促進脂肪酸 β-氧化
  general:
    - 食道管 (esophagostomy tube) 放置 — 長期營養支持首選 (4-6 週)
    - 管灌飲食：高蛋白 (30-40% ME)、適度脂肪，避免碳水化合物為主
    - 初始少量多餐 (RER 的 25% 起始，3-5 天內漸增至 100%)
    - 再餵食症候群預防：補充磷 (KPO4) 、鉀、鎂
    - IV 輸液 (避免含 dextrose 的液體)
    - Taurine 補充 (250 mg/cat/day)
    - Thiamine (Vit B1) 補充 (100 mg/cat/day)
    - 肝性腦病：lactulose 0.5 mL/kg PO BID-TID

prognosis: 積極營養支持下存活率約 60-85%。食道管管灌飲食至少 4-6 週，部分需 8-12 週。預後取決於潛在原發疾病是否可控。原發性較繼發性預後略佳。自主進食恢復為停止管灌的指標。

ontologyMappings:
  - source: MONDO
    code: "MONDO:0001146"
    label: fatty liver disease
    confidence: broad

guidelineRefs:
  - sourceOrg: ACVIM
    title: ACVIM Consensus Statement on the Management of Hepatic Disorders in Cats
    url: https://pubmed.ncbi.nlm.nih.gov/19175084/
    type: consensus
    pmid: "19175084"
  - sourceOrg: Journal of feline medicine and surgery
    title: "Feline abdominal ultrasonography: what's normal? what's abnormal? The liver."
    url: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10814177/
    type: review
    pmid: "30763154"
  - sourceOrg: Journal of feline medicine and surgery
    title: "Hepatic lipidosis: Clinical review drawn from collective effort."
    url: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10816292/
    type: review
    pmid: "29478399"
  - sourceOrg: Journal of feline medicine and surgery
    title: "Pancreatitis in cats: is it acute, is it chronic, is it significant?"
    url: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11104045/
    type: review
    pmid: "24794036"
pubmedQueries:
  - query: '"hepatic lipidosis" AND (cat OR feline) AND ("treatment" OR "nutrition" OR "esophagostomy")'
    frequency: monthly
